Pharmaceutical formulation for enhancing biodistribution of the lung or brain including byakangelicin

摘要

The present invention relates to a pharmaceutical formulation for enhancing lung or brain biodistribution comprising non-canzelisin, and more specifically, enhancing the biodistribution of a drug for treating lung disease or brain disease and a pharmaceutical formulation comprising non-canzelisin Regarding the effect, in the case of a pharmaceutical formulation containing an active ingredient such as curcumin, umbelliferone or doxorubicin of the present invention, and biacan jellycin, the biodistribution is concentrated in the lungs and brain, while not affecting other organs. It is possible to check the effect and directly analyze the distribution of the active ingredient by the method of fluorescence imaging, and analyze the active ingredient without problems such as denaturation and concentration change of the active substance during the pretreatment process or extraction process of a biological sample. In addition, there is an effect that can easily and quickly see the effect of enhancing the biodistribution of active substances in vivo.